{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T17:35:53Z","timestamp":1773509753522,"version":"3.50.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:p>One of the most serious complications of advanced melanoma is the diffusion of cancer cells to the central nervous system. The diagnosis of leptomeningeal metastasis (LMM) is notoriously challenging and requires a combination of consistent MRI and cerebrospinal fluid (CSF) cytology. In ambiguous cases, mutations like BRAF V600E in CSF-cell-free (cf)DNA may help to clarify diagnosis of LMM. Here we present the case of a young woman who developed isolated LMM after the diagnosis of a node-positive primary melanoma with normal LDH. The CSF was negative for tumour cells by cytology but positive for cfDNA BRAF V600E mutation, thus allowing us to diagnose LMM. To our knowledge, this is the first case where CSF sampling for the detection of BRAF mutation was used to identify leptomeningeal disease in the presence of negative MRI and without involvement of any other distant sites.<\/jats:p>","DOI":"10.1097\/cmr.0000000000000786","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T14:00:48Z","timestamp":1635256848000},"page":"55-58","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Leptomeningeal dissemination as a first sign of progression in metastatic melanoma: a diagnostic lesson"],"prefix":"10.1097","volume":"32","author":[{"given":"Michele","family":"Parietti","sequence":"first","affiliation":[{"name":"Dermatologic Clinic, Department of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Marra","sequence":"additional","affiliation":[{"name":"Dermatologic Clinic, Department of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Ribero","sequence":"additional","affiliation":[{"name":"Dermatologic Clinic, Department of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona Osella","family":"Abate","sequence":"additional","affiliation":[{"name":"Pathology Unit, Department of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Francia di Celle","sequence":"additional","affiliation":[{"name":"Pathology Unit, Department of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Rud\u00e0","sequence":"additional","affiliation":[{"name":"Neurologic Clinic, Department of Neuroscience, University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Quaglino","sequence":"additional","affiliation":[{"name":"Dermatologic Clinic, Department of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Fierro","sequence":"additional","affiliation":[{"name":"Dermatologic Clinic, Department of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,10,22]]},"reference":[{"key":"R1-20250528","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/ijc.30147","article-title":"Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy.","volume":"139","author":"Smalley","year":"2016","journal-title":"Int J Cancer"},{"key":"R2-20250528","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/107327481302000407","article-title":"Novel treatments for melanoma brain metastases.","volume":"20","author":"Kenchappa","year":"2013","journal-title":"Cancer Control"},{"key":"R3-20250528","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1215\/15228517-2007-058","article-title":"Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features.","volume":"10","author":"Raizer","year":"2008","journal-title":"Neuro Oncol"},{"key":"R4-20250528","first-page":"1079","article-title":"Leptomeningeal metastasis in melanoma: a prospective clinical study of nine patients.","volume":"26","author":"Pape","year":"2012","journal-title":"In Vivo"},{"key":"R5-20250528","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/1097-0142(19830101)51:1<154::AID-CNCR2820510130>3.0.CO;2-K","article-title":"Leptomeningeal carcinomatosis. How does cancer reach the pia-arachnoid?","volume":"51","author":"Kokkoris","year":"1983","journal-title":"Cancer"},{"key":"R6-20250528","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1215\/15228517-2008-062","article-title":"Prognostic factors and outcomes in patients with leptomeningeal melanomatosis.","volume":"10","author":"Harstad","year":"2008","journal-title":"Neuro Oncol"},{"key":"R7-20250528","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.4103\/2152-7806.111304","article-title":"Carcinomatous meningitis: leptomeningeal metastases in solid tumors.","volume":"4","author":"Le Rhun","year":"2013","journal-title":"Surg Neurol Int"},{"key":"R8-20250528","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<733::AID-CNCR17>3.0.CO;2-Z","article-title":"Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results.","volume":"82","author":"Glantz","year":"1998","journal-title":"Cancer"},{"key":"R9-20250528","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1373\/clinchem.2014.235457","article-title":"Brain tumour mutations detected in cerebral spinal fluid.","volume":"61","author":"Pan","year":"2015","journal-title":"Clin Chem"},{"key":"R10-20250528","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature12065","article-title":"Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA.","volume":"497","author":"Murtaza","year":"2013","journal-title":"Nature"},{"key":"R11-20250528","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1245\/s10434-018-6513-7","article-title":"Melanoma staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond.","volume":"25","author":"Gershenwald","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"R13-20250528","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/archneur.1996.00550070064013","article-title":"Leptomeningeal carcinomatosis. Presenting features and prognostic factors.","volume":"53","author":"Balm","year":"1996","journal-title":"Arch Neurol"},{"key":"R14-20250528","doi-asserted-by":"crossref","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","article-title":"\u201cDetection of circulating tumour DNA in early- and late-stage human malignancies.\u201d.","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci Transl Med"},{"key":"R15-20250528","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/pcmr.12652","article-title":"Leptomeningeal melanoma-A case series in the era of modern systemic therapy.","volume":"31","author":"Arasaratnam","year":"2018","journal-title":"Pigment Cell Melanoma Res"},{"key":"R16-20250528","doi-asserted-by":"crossref","first-page":"85430","DOI":"10.18632\/oncotarget.13397","article-title":"Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies.","volume":"7","author":"Momtaz","year":"2016","journal-title":"Oncotarget"},{"key":"R17-20250528","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/annonc\/mdy009","article-title":"Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy.","volume":"29","author":"Li","year":"2018","journal-title":"Ann Oncol"},{"key":"R18-20250528","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12885-019-5348-3","article-title":"Different next-generation sequencing pipelines based detection of tumour DNA in cerebrospinal fluid of lung adenocarcinoma cancer patients with leptomeningeal metastases.","volume":"19","author":"Mengxi","year":"2019","journal-title":"BMC Cancer"},{"key":"R19-20250528","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.ctrv.2013.06.004","article-title":"The use of systemic therapies for the treatment of brain metastases in metastatic melanoma: opportunities and unanswered questions.","volume":"39","author":"Murrella","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"R20-20250528","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S1470-2045(12)70431-X","article-title":"Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial.","volume":"13","author":"Long","year":"2012","journal-title":"Lancet Oncol"},{"key":"R21-20250528","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/157339411797642597","article-title":"Leptomeningeal metastasis: challenges in diagnosis and treatment.","volume":"7","author":"Leal","year":"2011","journal-title":"Curr Cancer Ther Rev"},{"key":"R22-20250528","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jnen\/nly046","article-title":"Evaluating circulating tumor DNA from the cerebrospinal fluid of patients with melanoma and leptomeningeal disease.","volume":"77","author":"Ballester","year":"2018","journal-title":"J Neuropathol Exp Neurol"},{"key":"R23-20250528","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/CMR.0000000000000162","article-title":"Cerebrospinal fluid concentrations of vemurafenib in patients treated for brain metastatic BRAF-V600 mutated melanoma.","volume":"25","author":"Sakji-Dupr\u00e9","year":"2015","journal-title":"Melanoma Res"},{"key":"R24-20250528","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/CMR.0000000000000274","article-title":"A rare case of leptomeningeal carcinomatosis in a patient with uveal melanoma: case report and review of literature.","volume":"26","author":"Fedorenko","year":"2016","journal-title":"Melanoma Res"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CMR.0000000000000786","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T21:45:34Z","timestamp":1748468734000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CMR.0000000000000786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,22]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0000000000000786","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,22]]}}}